Our portfolio

The SEA project represents one of the biggest concession contracts in Europe. The 50-year contract will cover the financing, design, construction, operation and maintenance of the 303 kilometres high-speed rail link between Tours and Bordeaux. This high-speed rail link will reduce the travel time of 55 minutes between Paris and Bordeaux.
Ardian remains asset manager and/or advisor.

Founded in 1998, Zabka is the owner of one of the largest network of convenience stores in Poland. With 2,400 stores, Zabka covers all the country, especially in large cities. In 2009, the company launched a new brand, called Freshmarket, which focuses on the medium-sized stores market. Ardian reinvested in the company in June 2013.

Founded in August 1996, NCI was the third largest Chinese player in the life insurance sector with 9% of the market share in 2010. Based in Beijing, NCI has 34 regional subsidiaries. NCI takes advantage of the strong growth of the Chinese market in this sector while seizing opportunites to increase its profitability.

Founded in 2005, Envision Healthcare (ex-EMSC) is the leading provider of emergency medical services in the United States. Envision Healthcare operates in two business segments: the healthcare transportation services with American Medical Response Inc. (AMR) and the physician services for emergency department with EmCare Holdings Inc. (EmCare). Envision Healthcare provides services each year to more than 13 million patients in more than 2,000 communities nationwide.

Spin off from Orange in 2005, TICKET SURF International has become one of the leading providers of e-money services offering prepaid cards : TICKET SURF, TICKET PREMIUM and prepaid MASTERCARD ULTREIA. After a strong development in the e-gaming market, TSI will achieve a deeper penetration in the international e-commerce.

Sequens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.